Asian Spectator


The Times

.

Guangdong Goods Go Global Promotional Video Released, Extending an Invitation to the World from Guangdong

SHENZHEN, CHINA – Media OutReach Newswire – 18 November 2026 – On November 18–19, the 33rd APEC Economic Leaders' Meeting kicks off in Shenzhen, drawing global attention to Gu...

Reborn Interior Expands Team to 60 Designers as Singapore Renovation Firm Scales Operations

SINGAPORE - Media OutReach Newswire - 24 August 2026 — Singapore-based interior design and renovation company Reborn Interior Pte. Ltd. has expanded its team to approximately 60 inter...

USSC Group Announces Rebranding, Changes Name to United Safety

EXTON, Pennsylvania, June 26, 2020 /PRNewswire-AsiaNet/ -- -- The company has positioned itself as a global leader in safety and survivability, unveiling a new name, logo, and look.Joe Mira...

Practical Methods Offers Anti-Counterfeiting and Traceability ...

BEAVERTON, Ore., Apr. 15, 2021 /PRNewswire-AsiaNet/ -- -- Extends Digimarc Barcode into South Korea under edgecode(R) brandDigimarc Corporation ( https://c212.net/c/link/?t=0&l=en&o=...

Patience Is Being Repriced as Government Borrowing, AI And Energy Compete For Long-Term Capital: GIC CEO Lim Chow Kiat

Fifth WMI Global-Asia Family Office Summit examines portfolio resilience and next-generation readiness as WMI research identifies meaningful participation as a key marker of preparednessSING...

Galaxy Macau™ Presents: Jimmy O. Yang Live in Macau Is Set to Delight Macau Audiences at Broadway Theatre from July 4-6

Tickets will go on public sale on June 13MACAU SAR - Media OutReach Newswire – 11 June 2025 -One of America's hottest comedy stars, Jimmy O. Yang is set to make his Macau debut this s...

SGO to participate in 'PLASTIC JAPAN 2022' in Japan 'EXCON 2...

SEOUL, South Korea, May 9, 2022 /PRNewswire-AsiaNet/ -- SGO, a Korean oilless bearing manufacturer, will participate in Plastic Japan being held in Osaka, Japan from May 11th to 13th, and EX...

Leanne Zeng, Vice President of Global Affairs at TCSA, was Inv...

PARIS, Nov. 12, 2020 /PRNewswire-AsiaNet/ -- Leanne Zeng, Vice President of Global Affairs at Thousand Cities Strategic Algorithms Cloud Technology (TCSA), attended a panel that explored "Th...

Dongying, China: Setting an Example and Benchmark for Ecologic...

DONGYING, China, Oct. 26, 2022 /Xinhua-AsiaNet/-- Oriental white storks have recently settled into the Yellow River Delta National Nature Reserve in Dongying, Shandong Province, bringing a u...

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

SYDNEY, Apr 8, 2020 - (ACN Newswire) - Asia-Pacific's largest specialist biotech CRO Novotech said the top 10 biotech sites in Australia were open for clinical trial activity with many sites modifying their practices to ensure continuity of operations.

Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity

View and Download the COVID-19 Australia Data Bulletin here. https://novotech-cro.com/covid-19-notice

The data is part of a new series prepared for Novotech clients detailing the current status of trials in the Asia-Pacific during the global COVID-19 crisis.

Novotech CEO Dr John Moller said the Bulletin series taps local knowledge of fundamentals in the sector and shows which countries in the region are able to support clinical research for Novotech and its clients during this time.

"While the situation is always evolving, Australia appears to be managing the crisis well. Our sites have changed how they manage trials in line with Australian Government health guidelines and most are still able to deliver the clinical trial services we need for our clients," said Dr Moller. "Study delays caused by COVID-19 can be rapidly addressed by activating new sites in Australia and Asia."

Australia has attractive start-up times, world leading investigators and research teams, and valuable rebates of up to 43.5% on clinical trial spend.

About Novotech

Novotech, established in 1996, is internationally recognized as the leading full-service contract research organization (CRO) in Asia-Pacific. Novotech provides clinical development services across all clinical trial phases and therapeutic areas and has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotech companies.

Novotech obtained the ISO 27001, the best-known standard in the ISO family, providing the requirements for an Information Security Management System. Together with the ISO 9001 Quality Management system, Novotech aims at the highest IT security and quality standards for patients and biotechnology companies. Visit http://novotech-cro.com.

For RFP enquiries: Please fill out the form available at https://novotech-cro.com/talk-to-an-expert

Media ContactSusan Fitzpatrick-Napiercommunications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

What to Consider Before Choosing a Cardboard Box Manufacturer

Start With the Packaging Purpose The right packaging begins with a clear understanding of what the box needs to do. A cardboard box manufacturer can help translate requirements such as product prot...

Why Emotional Battles Drain Your Wealth During Separation

Navigating a marriage ending is fundamentally a structural transition, not just an emotional event. When you approach separation with a clear roadmap, you protect your long term financial stability ...

How Long Does Botox Really Last? A Realistic Timeline

Someone might notice a line between their eyebrows getting deeper after a stressful week, or catch their forehead creasing in a video call in a way it did not before. It is a small observation, easy...

hacklink esim senegalzlibraryzlibraryuk casinos not on gamstophttps://www.capitolcitycinema.org/casino siteleriStreamEastStreamEastjojobetcialis 20 mg fiyat